Minimum monitoring capability should include: Baseline labs fasting glucose or A1c lipid panel CMP CBC When manipulating GH axis: IGF-1 Clinical monitoring body composition blood pressure heart rate symptom tracking If outcomes cannot be monitored, the stack should not proceed
Particular attention was given to recent randomized controlled trials (RCTs) such as SYNERGIC, DO-HEALTH, and PONDER, as well as large-scale epidemiological studies
Administration of L-carnitine in combination with orlistat or sibutramine has been shown to improve anthropomorphic, glycemic, and insulin parameters compared with L-carnitine monotherapy in patients with type 2 diabetes mellitus
P.JungJ
Liu dng L-Glutathione ng ch nh Dc s i hcNguyn Th Hng Nhung Tt nghip i hc Khoa Dc
77, 8294 10.1016/j.freeradbiomed.2014.09.007 [DOI] [PMC free article] [PubMed] [Google Scholar] 58.Everett S.A., Folkes L.K., Wardman P